{
    "title": "105_s2347",
    "content": "The Act may be cited as the \"Comprehensive Methamphetamine Abuse Reduction Act\" and aims to expand prevention efforts for methamphetamine abuse. The Comprehensive Methamphetamine Abuse Reduction Act includes a provision for grants to public and non-profit entities for school-based and community-based programs on methamphetamine abuse prevention. The Comprehensive Methamphetamine Abuse Reduction Act allows for grants to fund school-based and community-based prevention programs targeting populations at high risk for methamphetamine abuse. Local government entities can also receive assistance for prevention activities, and training is provided for State and local officials. The Director prioritizes grants for areas with high rates of methamphetamine abuse for training, education, prevention planning, monitoring, evaluation, and pilot programs to encourage innovation. The Director allocates funds for analyses and evaluations of prevention programs for methamphetamine abuse and addiction, with a focus on disseminating effective strategies. $20,000,000 is authorized for these efforts. The Director allocates $20,000,000 for analyses and evaluations of prevention programs for methamphetamine abuse and addiction, with funds to be appropriated annually for this purpose. SEC. 3. EXPANDING CRIMINAL PENALTIES AND LAW ENFORCEMENT FUNDING. The United States Sentencing Commission will amend sentencing guidelines for offenses related to manufacturing methamphetamine in violation of drug laws. This includes increasing the base offense level for such crimes. The United States Sentencing Commission will amend sentencing guidelines for manufacturing methamphetamine offenses by increasing the base offense level, with specific provisions for creating substantial risk of danger to others. The United States Sentencing Commission will amend guidelines for methamphetamine offenses by increasing the base offense level, with provisions for creating danger to others. The amendments will apply to offenses occurring 60 days after the enactment of the Act. The Commission must act promptly to implement the changes. Increased resources for law enforcement to combat methamphetamine trafficking in designated areas, with $25 million authorized for fiscal year 1999 and additional funding for fiscal years 2000 through 2004. SEC. 4. TREATMENT OF METHAMPHETAMINE ABUSE. Section 507 of the Public Health Service Act is amended to allow grants for expanding treatment programs for methamphetamine abuse and addiction. Funds can be used for evidence-based programs to help individuals quit methamphetamine use. The amended Section 507 of the Public Health Service Act allows grants for expanding treatment programs for methamphetamine abuse and addiction. This includes training health professionals in recognizing and treating methamphetamine abuse, planning and administering treatment activities, and monitoring and evaluating treatment outcomes. The Director prioritizes grants for rural and urban areas with high rates of methamphetamine abuse. Up to $1,000,000 is allocated annually for analyses and evaluations of effective treatments for methamphetamine abuse. The Director prioritizes grants for rural and urban areas with high rates of methamphetamine abuse. Up to $1,000,000 is allocated annually for analyses and evaluations of effective treatments for methamphetamine abuse. The Director shall submit an annual report to the Senate and House Committees on the results of the analyses and evaluations. $40,000,000 is authorized for fiscal year 1999, with additional funding for succeeding years as needed. SEC. 5. EXPANDING METHAMPHETAMINE RESEARCH. Section 464N of the Public Health Service Act is amended to allow grants for interdisciplinary research on methamphetamine abuse and addiction, focusing on its effects on the body, addictive nature, connection to mental illness, and prevention methods. The amended Section 464N of the Public Health Service Act allows grants for interdisciplinary research on methamphetamine abuse and addiction, focusing on treatment methods, risk factors, effects on pregnant women, and reasons for abuse. The Director is required to disseminate research results to relevant entities, with an authorization of $16,000,000 for fiscal year 1999 and additional funding for succeeding years."
}